Class II · Moderate risk
Lansoprazole Delayed-Release Capsules USP
CGMP Deviations
National Drug Code
Is NDC 16571-0742-41 recalled?
Lansoprazole Delayed-Release Capsules USP
Yes — this exact package was recalled
2 FDA recalls name the code 16571-0742-41 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
This code is not in the current FDA NDC directory — usual for a product that has since been discontinued or repackaged. The details below come from the recall notices themselves.
Recalls naming this package
Class II · Moderate risk
Lansoprazole Delayed-Release Capsules USP
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 16571-0130 See recall 2
- 16571-0140 See recall 2
- 16571-0141 See recall 2
- 16571-0402 Cetirizine Hydrochloride 2
- 16571-0301 See recall 1
- 16571-0302 See recall 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.